HCA Holdings (NYSE: HCA) reported Q4 EPS of $6.22, $0.08 better than the analyst estimate of $6.14. Revenue for the quarter came in at $18.29 billion versus the consensus estimate of $18.23 billion.

• The HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $10 billion of the Company’s outstanding common stock. Repurchases will be made in accordance with applicable securities laws and may be made at management’s discretion from time to time in the open market, through privately negotiated transactions, or otherwise. The repurchase program has no time limit and may be suspended for periods or discontinued at any time.

GUIDANCE:

HCA Holdings sees FY2025 EPS of $24.05-$25.85, versus the consensus of $24.61. HCA Holdings sees FY2025 revenue of $72.8-75.8 billion, versus the consensus of $74.81 billion.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.